BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2218445)

  • 1. [Chronic urticaria and acquired complement deficiency due to a nephritic factor (C3NeF)].
    Borradori L; Rybojad M; Weiss L; Späth P; Puissant A; Morel P
    Schweiz Med Wochenschr; 1990 Aug; 120(34):1236-41. PubMed ID: 2218445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M; Balow JE; Tsokos GC
    J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
    Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
    Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic urticaria and moderate leukocytoclastic vasculitis associated with C3 nephritic factor activity.
    Borradori L; Rybojad M; Morel P; Puissant A; Weiss L
    Arch Dermatol; 1989 Nov; 125(11):1589-90. PubMed ID: 2817926
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement activation in acute glomerulonephritis in children.
    Levy M; Sich M; Pirotzky E; Habib R
    Int J Pediatr Nephrol; 1985; 6(1):17-24. PubMed ID: 3997368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M; Sich M; Habib R
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
    Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; May A; Palomera S; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(12):1747-50. PubMed ID: 7708258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.
    West CD; Ruley EJ; Spitzer RE; Davis NC
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():531-40. PubMed ID: 4620926
    [No Abstract]   [Full Text] [Related]  

  • 15. Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor.
    Thompson RA; Yap PL; Brettle RB; Dunmow RE; Chapel H
    Clin Exp Immunol; 1983 Apr; 52(1):153-6. PubMed ID: 6861372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S; Tamura N; Fujita T
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
    Power DA; Ng YC; Simpson JG
    Q J Med; 1990 Apr; 75(276):387-98. PubMed ID: 2385743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
    Ruley EJ; Forristal J; Davis NC; Andres C; West CD
    J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of nephritic factor as an immunoglobulin.
    Williams DG; Bartlett A; Duffus P
    Clin Exp Immunol; 1978 Sep; 33(3):425-9. PubMed ID: 104814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypocomplementemic urticarial vasculitis syndrome].
    Sessler R; Hasche G; Olbricht CJ
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1003-6. PubMed ID: 11004912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.